KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Amortizatization of Intangibles for 14 consecutive years, with $661000.0 as the latest value for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles fell 90.7% year-over-year to $661000.0; the TTM value through Mar 2026 reached $3.8 million, up 1932.09%, while the annual FY2025 figure was $10.2 million, 338.66% up from the prior year.
  • Amortizatization of Intangibles hit $661000.0 in Q1 2026 for Ionis Pharmaceuticals, up from -$7.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $21.7 million in Q4 2023 and bottomed at -$8.5 million in Q2 2022.
  • Average Amortizatization of Intangibles over 5 years is $2.8 million, with a median of $661000.0 recorded in 2026.
  • On a YoY basis, Amortizatization of Intangibles climbed as much as 648.15% in 2025 and fell as far as 1802.83% in 2025.
  • Ionis Pharmaceuticals' Amortizatization of Intangibles stood at $3.4 million in 2022, then skyrocketed by 538.3% to $21.7 million in 2023, then crashed by 97.88% to $459000.0 in 2024, then plummeted by 1802.83% to -$7.8 million in 2025, then skyrocketed by 108.46% to $661000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $661000.0, -$7.8 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.